First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
Penumbra initiated the FORWARD study, enrolling the first patient to evaluate mechanical thrombectomy and Computer Assisted Vacuum Thrombectomy (CAVT) for distal acute ischemic stroke. The real-world, multi-center study plans to enroll up to 250 participants across approximately 40 sites, focusing on Penumbra's RED reperfusion catheter portfolio and THUNDERBOLT platform for M2 occlusions.
Key figures
- Study sites
- 40
- Study participants
- 250
- Distal occlusion pct
- 25-40
- Annual m2 strokes estimate
- 21,000-66,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.